iBET & GenIbet were present at the ASCGT annual meeting in Chicago
21.05.2018The meeting included one oral presentation by iBET and a showcase area, where iBET & GenIbet were exhibiting.
iBET was present at the 350-Year anniversary of Merck
17.05.2018Manuel Carrondo and Paula Alves were among the few international attendees of the celebration
New paper in collaboration with the Eppendorf AG Bioprocess Center just published
08.05.2018Culture of 3D Cell Aggregates in Perfusion in a DASbox® Mini Bioreactor System
iBET & GenIbet are now exhibiting at CPhI North America in Philadelphia.
24.04.2018iBET & GenIbet, through PharmaPortugal, were present for the first time at the CPhI North America 2018 - International Pharmaceutical Industry Convention, which ran from April 24 to 26 in Philadelphia, USA.
Best Poster Award for Diana Silva, junior researcher at the Structural Biology 4 Drug Discovery Group of iBET
13.04.2018The award work was presented at the "First Instruct / CIISB Course on Fragment Screening using crystallography laboratory equipment" course that took place early April in Vestec, Czech Republic
Inauguration of iBET's Technological Platform
07.04.2018The inauguration took place on April 6 and counted with the presence of the General Assembly of iBET
The new edition of iBET's Facts & Figures is now available... check it out
03.04.2018Our most recent news and accomplishments... read all about them!
Research on functional personalized cells published on Nature Communications
12.03.2018iBET and partners demonstrate that gene transfer and cell-type-specific regimens allow the reproducible creation of cell lines required for fundamental research and drug development for personalized medicine
NEW OPEN CALL: TRANSVAC - European Vaccine Research and Development Infrastructure
22.02.2018We have now opened the TRANSVAC TNA call 02. The second cut-off date for proposal submission for the open TRANSVAC Call is on 15 April 2018.
Introducing innate immunity to 3D tumour models
21.02.2018iBET and ITQB NOVA researchers developed a new 3D cell culture model to study the impact of the immune microenvironment of solid tumours in tumour progression and therapeutic response. The work was published in the journal Biomaterials